Volker Lang

Managing Director bei AbCheck

Volker Lang is the Managing Director of AbCheck, a biotechnology company specializing in antibody discovery and optimization.1 2 Here are some key details about him:

Professional Background

Volker Lang has over 18 years of successful experience in the biotechnology sector.4
His expertise spans basic research, industry R&D, business development, and general management.4

Role at AbCheck

As Managing Director, Volker Lang leads AbCheck, which was founded in 2009 as a spin-out of Affimed's antibody technology discovery unit.3
He oversees a lean and agile team of experts with more than 20 years of experience in antibody discovery and development.3

Recent Developments

In January 2024, AbCheck was acquired by Ampersand Biomedicines, a Flagship Pioneering company.1 2
Following the acquisition, Volker Lang expressed enthusiasm about joining Ampersand, stating: "We're thrilled to join Ampersand and further our potential to discover and optimize novel antibodies against challenging disease targets through AND-body medicines."1 2

Company Leadership

AbCheck, under Volker Lang's leadership, has built one of the leading antibody discovery and optimization platforms with a highly successful track record.1 2
The company has validated its platform through more than 45 partnerships with biopharma companies and produced multiple clinical candidates.1 2

Volker Lang's LinkedIn profile can be found under the username volker-lang-07814b52, as mentioned in the query.